Transvenous leads increase thromboembolic risk in patients with intracardiac shunts
This article has no abstract so we have provided the first paragraph of the full text.
Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and transvenous pacemaker or ICD leads are associated with a potential for systemic thromboemboli. Khairy et al. have, therefore, investigated the risk of systemic thromboemboli associated with transvenous leads in patients with intracardiac shunts.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
